Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921763717> ?p ?o ?g. }
- W2921763717 endingPage "1235" @default.
- W2921763717 startingPage "1230" @default.
- W2921763717 abstract "Background: In vivo amniotic fluid is known to contain a population of mesenchymal stem cells (MSCs) and growth factors and has been shown to assist in healing when used as an adjunct in procedures across multiple medical specialties. It is unclear whether amniotic fluid products (AFPs) contain MSCs and, if so, whether the cells remain viable after processing. Purpose: To determine whether MSCs, growth factors, and hyaluronan are present in commercially available AFPs. Study Design: Descriptive laboratory study. Methods: Seven commercial companies that provide amniotic fluid were invited to participate in the study; 3 companies (the manufacturers of PalinGen, FloGraft, and Genesis AFPs) agreed to participate and donated AFPs for analysis. The AFPs were evaluated for the presence of MSCs, various growth factors relevant to orthopaedics (platelet-derived growth factor ββ, vascular endothelial growth factor, interleukin 8, bone morphogenetic protein 2, transforming growth factor β 1 ), and hyaluronan by enzyme-linked immunosorbent assay and culture of fibroblast colony-forming units. These products were compared with unprocessed amniotic fluid and 2 separate samples of MSCs derived from human bone marrow aspirates. All groups used the same culture medium and expansion techniques. Identical testing and analysis procedures were used for all samples. Results: MSCs could not be identified in the commercial AFPs or the unprocessed amniotic fluid. MSCs could be cultured from the bone marrow aspirates. Nucleated cells were found in 2 products (PalinGen and FloGraft), but most of these cells were dead. The few living cells did not exhibit established characteristics of MSCs. Growth factors and hyaluronan were present in all groups at varying levels. Conclusion: The AFPs studied should not be considered “stem cell” therapies, and researchers should use caution when evaluating commercial claims that products contain stem cells. Given their growth factor content, however, AFPs may still represent a promising tool for orthopaedic treatment. Clinical Relevance: Amniotic fluid has been proposed as an allogenic means for introducing MSCs. This study was unable to confirm that commercial AFPs contain MSCs." @default.
- W2921763717 created "2019-03-22" @default.
- W2921763717 creator A5030617316 @default.
- W2921763717 creator A5046479284 @default.
- W2921763717 creator A5078579943 @default.
- W2921763717 creator A5082534632 @default.
- W2921763717 creator A5082724975 @default.
- W2921763717 date "2019-03-07" @default.
- W2921763717 modified "2023-09-27" @default.
- W2921763717 title "Are Amniotic Fluid Products Stem Cell Therapies? A Study of Amniotic Fluid Preparations for Mesenchymal Stem Cells With Bone Marrow Comparison" @default.
- W2921763717 cites W1831008608 @default.
- W2921763717 cites W1969717580 @default.
- W2921763717 cites W1972788455 @default.
- W2921763717 cites W1988438360 @default.
- W2921763717 cites W1988894222 @default.
- W2921763717 cites W1998650056 @default.
- W2921763717 cites W2008716980 @default.
- W2921763717 cites W2018265301 @default.
- W2921763717 cites W2025371271 @default.
- W2921763717 cites W2037618281 @default.
- W2921763717 cites W2050483163 @default.
- W2921763717 cites W2056136503 @default.
- W2921763717 cites W2075092713 @default.
- W2921763717 cites W2095392254 @default.
- W2921763717 cites W2097694021 @default.
- W2921763717 cites W2136777666 @default.
- W2921763717 cites W2141676073 @default.
- W2921763717 cites W2144268541 @default.
- W2921763717 cites W2150384215 @default.
- W2921763717 cites W2164988686 @default.
- W2921763717 cites W2178649140 @default.
- W2921763717 cites W2199255753 @default.
- W2921763717 cites W2337958855 @default.
- W2921763717 cites W2489169965 @default.
- W2921763717 cites W2608209876 @default.
- W2921763717 cites W2893622258 @default.
- W2921763717 doi "https://doi.org/10.1177/0363546519829034" @default.
- W2921763717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30844295" @default.
- W2921763717 hasPublicationYear "2019" @default.
- W2921763717 type Work @default.
- W2921763717 sameAs 2921763717 @default.
- W2921763717 citedByCount "24" @default.
- W2921763717 countsByYear W29217637172019 @default.
- W2921763717 countsByYear W29217637172020 @default.
- W2921763717 countsByYear W29217637172021 @default.
- W2921763717 countsByYear W29217637172022 @default.
- W2921763717 countsByYear W29217637172023 @default.
- W2921763717 crossrefType "journal-article" @default.
- W2921763717 hasAuthorship W2921763717A5030617316 @default.
- W2921763717 hasAuthorship W2921763717A5046479284 @default.
- W2921763717 hasAuthorship W2921763717A5078579943 @default.
- W2921763717 hasAuthorship W2921763717A5082534632 @default.
- W2921763717 hasAuthorship W2921763717A5082724975 @default.
- W2921763717 hasBestOaLocation W29217637172 @default.
- W2921763717 hasConcept C109661977 @default.
- W2921763717 hasConcept C123012128 @default.
- W2921763717 hasConcept C126322002 @default.
- W2921763717 hasConcept C142724271 @default.
- W2921763717 hasConcept C16685009 @default.
- W2921763717 hasConcept C170493617 @default.
- W2921763717 hasConcept C172680121 @default.
- W2921763717 hasConcept C198826908 @default.
- W2921763717 hasConcept C202751555 @default.
- W2921763717 hasConcept C203014093 @default.
- W2921763717 hasConcept C20875687 @default.
- W2921763717 hasConcept C2775960820 @default.
- W2921763717 hasConcept C2777587049 @default.
- W2921763717 hasConcept C2778194526 @default.
- W2921763717 hasConcept C2779234561 @default.
- W2921763717 hasConcept C2780007613 @default.
- W2921763717 hasConcept C28328180 @default.
- W2921763717 hasConcept C2908647359 @default.
- W2921763717 hasConcept C54355233 @default.
- W2921763717 hasConcept C55493867 @default.
- W2921763717 hasConcept C71924100 @default.
- W2921763717 hasConcept C86803240 @default.
- W2921763717 hasConcept C95444343 @default.
- W2921763717 hasConcept C99454951 @default.
- W2921763717 hasConceptScore W2921763717C109661977 @default.
- W2921763717 hasConceptScore W2921763717C123012128 @default.
- W2921763717 hasConceptScore W2921763717C126322002 @default.
- W2921763717 hasConceptScore W2921763717C142724271 @default.
- W2921763717 hasConceptScore W2921763717C16685009 @default.
- W2921763717 hasConceptScore W2921763717C170493617 @default.
- W2921763717 hasConceptScore W2921763717C172680121 @default.
- W2921763717 hasConceptScore W2921763717C198826908 @default.
- W2921763717 hasConceptScore W2921763717C202751555 @default.
- W2921763717 hasConceptScore W2921763717C203014093 @default.
- W2921763717 hasConceptScore W2921763717C20875687 @default.
- W2921763717 hasConceptScore W2921763717C2775960820 @default.
- W2921763717 hasConceptScore W2921763717C2777587049 @default.
- W2921763717 hasConceptScore W2921763717C2778194526 @default.
- W2921763717 hasConceptScore W2921763717C2779234561 @default.
- W2921763717 hasConceptScore W2921763717C2780007613 @default.
- W2921763717 hasConceptScore W2921763717C28328180 @default.
- W2921763717 hasConceptScore W2921763717C2908647359 @default.
- W2921763717 hasConceptScore W2921763717C54355233 @default.
- W2921763717 hasConceptScore W2921763717C55493867 @default.